Literature DB >> 33992051

An Updated Review of the Cross-talk Between MicroRNAs and Epigenetic Factors in Cancers.

Narges Dastmalchi1, Reza Safaralizadeh1, Seyed Mahdi Banan Khojasteh1, Mohammad Reza Sam2, Saeid Latifi-Navid3, Bashdar Mahmud Hussen4, Mahdi Abdoli Shadbad5, Behzad Baradaran6.   

Abstract

BACKGROUND: Growing evidence indicates that miRs have critical activities in adjusting cellular processes, e.g., cell death, proliferation, and cell-cycle.
INTRODUCTION: This study aimed to provide a concise review of the recent findings regarding tumoral miRs and the cross-talk between miRs and epigenetic factors.
RESULTS: Like the protein-coding genes, the expression levels of miRs are mediated by various transcriptional networks. Indeed, the expression of miRs could be epigenetically modulated by DNA methylation factors and histone modifiers. Furthermore, miRs can suppress critical factors, which mediate epigenetic modifications. Besides, miRs have been implicated in cancer development, metastasis, and chemo-resistance. The aberrant expression of miRs and dysregulated modulatory circuits between miRs and epigenetic factors participate in tumor progression.
CONCLUSION: Identifying tumoral miRs can provide ample opportunity to overcome chemo- resistance and bring a forefront treatment for affected patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; epigenetic; microRNA; modulatory circuit; protien coding genes; tumor progression.

Mesh:

Substances:

Year:  2021        PMID: 33992051     DOI: 10.2174/0929867328666210514125955

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  2 in total

1.  The combined restoration of miR-424-5p and miR-142-3p effectively inhibits MCF-7 breast cancer cell line via modulating apoptosis, proliferation, colony formation, cell cycle and autophagy.

Authors:  Narges Dastmalchi; Reza Safaralizadeh; Seyed Mahdi Banan Khojasteh; Mahdi Abdoli Shadbad; Mohammad Ali Hosseinpourfeizi; Shirin Azarbarzin; Ali Rajabi; Behzad Baradaran
Journal:  Mol Biol Rep       Date:  2022-06-06       Impact factor: 2.742

2.  A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.

Authors:  Mahdi Abdoli Shadbad; Sahar Safaei; Oronzo Brunetti; Afshin Derakhshani; Parisa Lotfinejad; Ahad Mokhtarzadeh; Nima Hemmat; Vito Racanelli; Antonio Giovanni Solimando; Antonella Argentiero; Nicola Silvestris; Behzad Baradaran
Journal:  Genes (Basel)       Date:  2021-08-04       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.